Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,925 | -41,483 | -28,728 | -11,103 | -26,567 |
| Depreciation Amortization | 723 | 543 | 364 | 177 | 898 |
| Accounts payable and accrued liabilities | 1,395 | 2,187 | 2,585 | 1,216 | -587 |
| Other Working Capital | 4,732 | 1,675 | 4,286 | -461 | -2,629 |
| Other Operating Activity | 6,012 | 3,782 | 1,561 | 986 | 3,647 |
| Operating Cash Flow | $-43,063 | $-33,296 | $-19,932 | $-9,186 | $-25,238 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,855 | -16,871 | -24,747 | -12,803 | N/A |
| PPE Investments | 354 | 175 | 83 | -6 | -246 |
| Investing Cash Flow | $-19,500 | $-16,697 | $-24,664 | $-12,809 | $-246 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 18 | 18 | 0 | 6 |
| Common Stock Repurchased | 30 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 83,557 |
| Financing Cash Flow | $30 | $18 | $18 | $0 | $83,562 |
| Beginning Cash Position | 68,416 | 68,416 | 68,416 | 68,416 | 10,337 |
| End Cash Position | 5,883 | 18,441 | 23,838 | 46,421 | 68,416 |
| Net Cash Flow | $-62,533 | $-49,975 | $-44,578 | $-21,994 | $58,079 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,063 | -33,296 | -19,932 | -9,186 | -25,238 |
| Capital Expenditure | -6 | -6 | -6 | -6 | -1,604 |
| Free Cash Flow | -43,069 | -33,302 | -19,938 | -9,192 | -26,842 |